Invention Grant
- Patent Title: Sequence specific antimicrobials
-
Application No.: US17707049Application Date: 2022-03-29
-
Publication No.: US11491209B2Publication Date: 2022-11-08
- Inventor: David Bikard , Luciano Marraffini
- Applicant: The Rockefeller University
- Applicant Address: US NY New York
- Assignee: The Rockefeller University
- Current Assignee: The Rockefeller University
- Current Assignee Address: US NY New York
- Agency: Hodgson Russ LLP
- Main IPC: A61K38/46
- IPC: A61K38/46 ; C12N9/16 ; A61K45/06 ; A61K31/7105 ; C12N15/113 ; A61K31/713 ; A01N63/00 ; C12N9/22 ; C12N15/74

Abstract:
Provided are compositions and methods for selectively reducing the amount of antibiotic resistant and/or virulent bacteria in a mixed bacteria population, or for reducing any other type of unwanted bacteria in a mixed bacteria population. The compositions and methods involve targeting bacteria that are differentiated from other members of the population by at least one unique clustered regularly interspaced short palindromic repeats (CRISPR) targeted DNA sequence. The compositions and methods can be readily adapted to target any bacteria or any bacteria plasmid, or both.
Public/Granted literature
- US20220218795A1 SEQUENCE SPECIFIC ANTIMICROBIALS Public/Granted day:2022-07-14
Information query
IPC分类: